These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17442709)

  • 1. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.
    Nie Z; Bren GD; Vlahakis SR; Schimnich AA; Brenchley JM; Trushin SA; Warren S; Schnepple DJ; Kovacs CM; Loutfy MR; Douek DC; Badley AD
    J Virol; 2007 Jul; 81(13):6947-56. PubMed ID: 17442709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome.
    Natesampillai S; Cummins NW; Nie Z; Sampath R; Baker JV; Henry K; Pinzone M; O'Doherty U; Polley EC; Bren GD; Katzmann DJ; Badley AD
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.
    Sampath R; Cummins NW; Natesampillai S; Bren GD; Chung TD; Baker J; Henry K; Pagliuzza A; Badley AD
    PLoS One; 2017; 12(6):e0179327. PubMed ID: 28628632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.
    Sainski AM; Dai H; Natesampillai S; Pang YP; Bren GD; Cummins NW; Correia C; Meng XW; Tarara JE; Ramirez-Alvarado M; Katzmann DJ; Ochsenbauer C; Kappes JC; Kaufmann SH; Badley AD
    J Cell Biol; 2014 Sep; 206(7):867-76. PubMed ID: 25246614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
    Cummins NW; Sainski AM; Dai H; Natesampillai S; Pang YP; Bren GD; de Araujo Correia MCM; Sampath R; Rizza SA; O'Brien D; Yao JD; Kaufmann SH; Badley AD
    J Virol; 2016 Apr; 90(8):4032-4048. PubMed ID: 26842479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication.
    Bren GD; Whitman J; Cummins N; Shepard B; Rizza SA; Trushin SA; Badley AD
    PLoS One; 2008 May; 3(5):e2112. PubMed ID: 18461165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casp8p41 expression in primary T cells induces a proinflammatory response.
    Taylor JA; Cummins NW; Bren GD; Rizza SA; Kolbert CP; Behrens MD; Knutson KL; Kahl JC; Asmann YW; Badley AD
    AIDS; 2010 Jun; 24(9):1251-8. PubMed ID: 20299954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.
    Sainski AM; Natesampillai S; Cummins NW; Bren GD; Taylor J; Saenz DT; Poeschla EM; Badley AD
    J Virol; 2011 Aug; 85(16):7965-75. PubMed ID: 21653671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.
    Natesampillai S; Nie Z; Cummins NW; Jochmans D; Bren GD; Angel JB; Badley AD
    PLoS Pathog; 2010 Nov; 6(11):e1001213. PubMed ID: 21124822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casp8p41 and HIV.
    Cummins NW; Badley AD
    Oncotarget; 2015 Sep; 6(27):23042-3. PubMed ID: 26309081
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular Casp8p41 content is inversely associated with CD4 T cell count.
    Cummins NW; Jiang W; McGinty J; Bren GD; Bosch RJ; Landay A; Deeks SG; Martin JN; Douek D; Lederman MM; Brenchley J; Badley AD
    J Infect Dis; 2010 Aug; 202(3):386-91. PubMed ID: 20565257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation.
    Nie Z; Phenix BN; Lum JJ; Alam A; Lynch DH; Beckett B; Krammer PH; Sekaly RP; Badley AD
    Cell Death Differ; 2002 Nov; 9(11):1172-84. PubMed ID: 12404116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells.
    Hoji A; Connolly NC; Buchanan WG; Rinaldo CR
    Clin Vaccine Immunol; 2007 Jan; 14(1):74-80. PubMed ID: 17079436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells.
    Carbonari M; Cibati M; Pesce AM; Sbarigia D; Grossi P; D'Offizi G; Luzi G; Fiorilli M
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):789-94. PubMed ID: 7546905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH; Gabuzda D
    J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.
    Cummins NW; Sainski-Nguyen AM; Natesampillai S; Aboulnasr F; Kaufmann S; Badley AD
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.
    Cummins NW; Neuhaus J; Sainski AM; Strausbauch MA; Wettstein PJ; Lewin SR; Plana M; Rizza SA; Temesgen Z; Touloumi G; Freiberg M; Neaton J; Badley AD;
    AIDS Res Hum Retroviruses; 2014 May; 30(5):476-9. PubMed ID: 24344953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.
    McBreen S; Imlach S; Shirafuji T; Scott GR; Leen C; Bell JE; Simmonds P
    J Virol; 2001 May; 75(9):4091-102. PubMed ID: 11287558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.